STOCK TITAN

[Form 4] THERMO FISHER SCIENTIFIC INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Jennifer M. Johnson, a director of Thermo Fisher Scientific Inc. (TMO), was credited with 67.31 Phantom Stock Units on September 27, 2025 under the issuer's Deferred Compensation Plan for Directors. Each unit is convertible into one share of common stock on a 1-for-1 basis and the units were credited at a stated price of $464.24 per unit. The units are distributable as stock when the director ceases service or upon a change of control. The filing notes the reporting person is an executive at Franklin Resources, Inc., and that Franklin Templeton subsidiaries may hold Thermo Fisher shares in client accounts; the reporting person disclaims beneficial ownership of those third-party holdings.

Jennifer M. Johnson, direttrice di Thermo Fisher Scientific Inc. (TMO), ha ricevuto l'accredito di 67,31 unità di Phantom Stock il 27 settembre 2025 ai sensi del piano di compensazione differita per i direttori dell'emittente. Ogni unità è convertibile in una azione ordinaria secondo un rapporto 1:1 e le unità sono registrate al prezzo dichiarato di $464,24 per unità. Le unità possono essere distribuite come azioni al termine della sua carica o in caso di cambio di controllo. Il documento segnala che la persona che presenta il rapporto è dirigente presso Franklin Resources, Inc., e che le filiali di Franklin Templeton potrebbero detenere azioni Thermo Fisher nei conti dei clienti; la persona che presenta il rapporto declina la titolarità beneficiaria di tali detenzioni di terzi.
Jennifer M. Johnson, directora de Thermo Fisher Scientific Inc. (TMO), recibió acreditación de 67.31 Phantom Stock Units el 27 de septiembre de 2025 bajo el plan de compensación diferida para directores del emisor. Cada unidad se puede convertir en una acción común en una base 1 a 1 y las unidades se acreditaron a un precio declarado de $464.24 por unidad. Las unidades pueden distribuirse como acciones cuando la directora termine su mandato o tras un cambio de control. El expediente señala que la persona que presenta el informe es ejecutiva en Franklin Resources, Inc., y que las filiales de Franklin Templeton pueden mantener acciones de Thermo Fisher en cuentas de clientes; la persona que presenta el informe niega la titularidad beneficiosa de esas participaciones de terceros.
제니퍼 M. 존슨은 Thermo Fisher Scientific Inc. (TMO)의 이사로, 발행사의 이사 보수계획에 따라 67.31 팬텀 주식 유닛2025년 9월 27일에 인정받았으며, 각 유닛은 1대 1의 비율로 보통주 1주로 전환할 수 있고 유닛은 주당 $464.24의 명시가에 기록되었다. 이 유닛은 이사가 근무를 중단하거나 지배권이 바뀔 때 주식으로 분배될 수 있다. 제출 문서는 보고서 작성자가 Franklin Resources, Inc.의 임원이며 Franklin Templeton 계열사가 고객 계좌에 Thermo Fisher 주식을 보유할 수 있음을 밝히고 있으며, 보고서는 제3자 보유에 대한 수익적 소유를 부인한다.
Jennifer M. Johnson, directrice de Thermo Fisher Scientific Inc. (TMO), a été créditée de 67.31 unités de Phantom Stock le 27 septembre 2025 dans le cadre du plan de rémunération différée pour les administrateurs de l'émetteur. Chaque unité peut être convertie en une action ordinaire sur une base 1 pour 1 et les unités ont été créditées au prix déclaré de $464,24 par unité. Les unités sont distribuables en actions lorsque la directrice cesse ses fonctions ou lors d'un changement de contrôle. Le dossier note que la personne qui dépose le rapport est cadre chez Franklin Resources, Inc., et que les filiales de Franklin Templeton peuvent détenir des actions Thermo Fisher dans les comptes de clients; la personne déposant le rapport déclare ne pas avoir de droits bénéfiques sur ces positions de tiers.
Jennifer M. Johnson, eine Direktorin von Thermo Fisher Scientific Inc. (TMO), wurde am 27. September 2025 unter dem Abspaltungskompensationsplan für Direktoren des Emittenten mit 67,31 Phantom Stock Units gutgeschrieben. Jede Einheit ist 1:1 in eine Stammaktie umwandelbar, und die Einheiten wurden zu einem angegebenen Preis von $464,24 pro Einheit gutgeschrieben. Die Einheiten können als Aktien ausgeschüttet werden, wenn die Direktorin ihr Amt niederlegt oder es zu einer Übernahme kommt. Die Einreichung vermerkt, dass die meldende Person als Führungskraft bei Franklin Resources, Inc. tätig ist und dass Franklin Templeton-Tochtergesellschaften Thermo Fisher-Aktien in Kundenkonten halten könnten; die meldende Person weist eine wirtschaftliche Eigentümerschaft an diesen Drittbeteiligungen zurück.
تَمَّ اعتماد 67.31 وحدة أسهم تناظرية لـ Jennifer M. Johnson، مديرة في Thermo Fisher Scientific Inc. (TMO)، في 27 سبتمبر 2025 بموجب خطة التعويض المؤجل للمديرين للمصدر. يمكن تحويل كل وحدة إلى سهم عادي بنسبة 1 مقابل 1، وتم تسجيل الوحدات بسعر مُصرَّح به قدره $464.24 للوحدة. يمكن توزيع الوحدات كسهم عند انتهاء خدمة المديرة أو عند حدوث تغيير في السيطرة. تشير الإيداع إلى أن الشخص المبلغ تقارير يعمل كتنفيذي في Franklin Resources, Inc., وأن فروع Franklin Templeton قد تحتفظ بأسهم Thermo Fisher في حسابات العملاء؛ reporters لا يملك الشخص المبلغ ملكية فائدة بتلك الحيازات من طرف ثالث.
Jennifer M. Johnson,Thermo Fisher Scientific Inc.(TMO)董事之一,在发行人对董事的延迟补偿计划下,于2025年9月27日获得 67.31份幻影股票单位的记名。每单位可按1:1转换为普通股,单位按$464.24/单位的列示价格记入。该单位在董事停止任期或发生控制权变更时可作为股票分配。文件提到报送人是 Franklin Resources, Inc. 的高管,Franklin Templeton 的子公司可能在客户账户中持有 Thermo Fisher 的股票;报送人声明对这些第三方持股不享有受益所有权。
Positive
  • Director compensation credited: 67.31 Phantom Stock Units were credited under the Deferred Compensation Plan, aligning pay with shareholder value.
  • Clear conversion terms: Units are convertible into common stock on a 1-for-1 basis and distributable upon cessation of service or a change of control.
  • Transparent disclosure: Filing includes a specific per-unit credit price of $464.24 and a disclaimer regarding Franklin Templeton-managed holdings.
Negative
  • None.

Insights

TL;DR: Routine director deferred-compensation crediting of 67.31 phantom units; immaterial to Thermo Fisher's cap table.

The transaction reported is a non-cash credit under the company's director deferred compensation plan: 67.31 phantom stock units were credited and are convertible 1-for-1 into common shares. Valuation per the filing is $464.24 per unit, reflecting how director retainers are deferred. This is a compensation administration event rather than a market-moving insider purchase or sale. No shares were sold or exercised and there is no change in voting control disclosed. Impact on outstanding shares or dilution is likely minimal given the small unit count relative to a large-cap issuer.

TL;DR: Standard director deferred-stock credit consistent with governance practices; disclosure and disclaimer are appropriate.

The Form 4 documents a typical deferred compensation credit to a director under the board's deferred plan. The filing clearly states conversion mechanics (1-for-1) and distribution conditions (cessation of service or change of control), which align with common director compensation structures. The report also includes a conflict-of-interest disclosure noting the reporting person's role at Franklin Resources and a disclaimer of beneficial ownership for assets managed by Franklin Templeton subsidiaries, which is prudent and transparent for governance purposes. No unusual governance risks or related-party transactions are identified in the filing text.

Jennifer M. Johnson, direttrice di Thermo Fisher Scientific Inc. (TMO), ha ricevuto l'accredito di 67,31 unità di Phantom Stock il 27 settembre 2025 ai sensi del piano di compensazione differita per i direttori dell'emittente. Ogni unità è convertibile in una azione ordinaria secondo un rapporto 1:1 e le unità sono registrate al prezzo dichiarato di $464,24 per unità. Le unità possono essere distribuite come azioni al termine della sua carica o in caso di cambio di controllo. Il documento segnala che la persona che presenta il rapporto è dirigente presso Franklin Resources, Inc., e che le filiali di Franklin Templeton potrebbero detenere azioni Thermo Fisher nei conti dei clienti; la persona che presenta il rapporto declina la titolarità beneficiaria di tali detenzioni di terzi.
Jennifer M. Johnson, directora de Thermo Fisher Scientific Inc. (TMO), recibió acreditación de 67.31 Phantom Stock Units el 27 de septiembre de 2025 bajo el plan de compensación diferida para directores del emisor. Cada unidad se puede convertir en una acción común en una base 1 a 1 y las unidades se acreditaron a un precio declarado de $464.24 por unidad. Las unidades pueden distribuirse como acciones cuando la directora termine su mandato o tras un cambio de control. El expediente señala que la persona que presenta el informe es ejecutiva en Franklin Resources, Inc., y que las filiales de Franklin Templeton pueden mantener acciones de Thermo Fisher en cuentas de clientes; la persona que presenta el informe niega la titularidad beneficiosa de esas participaciones de terceros.
제니퍼 M. 존슨은 Thermo Fisher Scientific Inc. (TMO)의 이사로, 발행사의 이사 보수계획에 따라 67.31 팬텀 주식 유닛2025년 9월 27일에 인정받았으며, 각 유닛은 1대 1의 비율로 보통주 1주로 전환할 수 있고 유닛은 주당 $464.24의 명시가에 기록되었다. 이 유닛은 이사가 근무를 중단하거나 지배권이 바뀔 때 주식으로 분배될 수 있다. 제출 문서는 보고서 작성자가 Franklin Resources, Inc.의 임원이며 Franklin Templeton 계열사가 고객 계좌에 Thermo Fisher 주식을 보유할 수 있음을 밝히고 있으며, 보고서는 제3자 보유에 대한 수익적 소유를 부인한다.
Jennifer M. Johnson, directrice de Thermo Fisher Scientific Inc. (TMO), a été créditée de 67.31 unités de Phantom Stock le 27 septembre 2025 dans le cadre du plan de rémunération différée pour les administrateurs de l'émetteur. Chaque unité peut être convertie en une action ordinaire sur une base 1 pour 1 et les unités ont été créditées au prix déclaré de $464,24 par unité. Les unités sont distribuables en actions lorsque la directrice cesse ses fonctions ou lors d'un changement de contrôle. Le dossier note que la personne qui dépose le rapport est cadre chez Franklin Resources, Inc., et que les filiales de Franklin Templeton peuvent détenir des actions Thermo Fisher dans les comptes de clients; la personne déposant le rapport déclare ne pas avoir de droits bénéfiques sur ces positions de tiers.
Jennifer M. Johnson, eine Direktorin von Thermo Fisher Scientific Inc. (TMO), wurde am 27. September 2025 unter dem Abspaltungskompensationsplan für Direktoren des Emittenten mit 67,31 Phantom Stock Units gutgeschrieben. Jede Einheit ist 1:1 in eine Stammaktie umwandelbar, und die Einheiten wurden zu einem angegebenen Preis von $464,24 pro Einheit gutgeschrieben. Die Einheiten können als Aktien ausgeschüttet werden, wenn die Direktorin ihr Amt niederlegt oder es zu einer Übernahme kommt. Die Einreichung vermerkt, dass die meldende Person als Führungskraft bei Franklin Resources, Inc. tätig ist und dass Franklin Templeton-Tochtergesellschaften Thermo Fisher-Aktien in Kundenkonten halten könnten; die meldende Person weist eine wirtschaftliche Eigentümerschaft an diesen Drittbeteiligungen zurück.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
JOHNSON JENNIFER M

(Last) (First) (Middle)
168 THIRD AVENUE

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units (1) 09/27/2025 A 67.31 (2) (2) Common Stock 67.31 (2) 541.36 D
Explanation of Responses:
1. Convertible into Common Stock on a 1-for-1 basis.
2. Represents stock units credited to the Reporting Person's account as of September 27, 2025, at a price of $464.24 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
Remarks:
Reporting Person is the President, Chief Executive Officer and a Director of Franklin Resources, Inc., a global investment management organization operating as Franklin Templeton?. Franklin Templeton subsidiaries manage investment products and client accounts that hold equity securities of the Issuer in the ordinary course of business. Reporting Person disclaims beneficial ownership of such securities.
/s/ Melodie T. Morin, Attorney-in-Fact for Jennifer M. Johnson 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

TMO Latest News

TMO Latest SEC Filings

TMO Stock Data

183.15B
376.95M
0.16%
91.87%
1.04%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States
WALTHAM